These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38786304)

  • 21. Evaluation of non-stenotic carotid atherosclerotic plaques with combined FDG-PET imaging and CT angiography in patients with ischemic stroke of unknown origin.
    Mikail N; Meseguer E; Lavallée P; Klein I; Hobeanu C; Guidoux C; Cabrejo L; Lesèche G; Amarenco P; Hyafil F
    J Nucl Cardiol; 2022 Jun; 29(3):1329-1336. PubMed ID: 33462787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients.
    Tawakol A; Migrino RQ; Bashian GG; Bedri S; Vermylen D; Cury RC; Yates D; LaMuraglia GM; Furie K; Houser S; Gewirtz H; Muller JE; Brady TJ; Fischman AJ
    J Am Coll Cardiol; 2006 Nov; 48(9):1818-24. PubMed ID: 17084256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined application of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in early diagnosis of vulnerable carotid atherosclerotic plaques.
    Lei-xing X; Jing-jing G; Jing-xue N; Juan W; Juan L; Chang-zai L; Xiao-xi W; Da-yi Y; Jia-jin L; Xiong-wei Z; Liu-quan C; Yong W; Dan-qing L; Hong-bin L
    J Int Med Res; 2014 Feb; 42(1):213-23. PubMed ID: 24366494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contemporary carotid imaging: from degree of stenosis to plaque vulnerability.
    Brinjikji W; Huston J; Rabinstein AA; Kim GM; Lerman A; Lanzino G
    J Neurosurg; 2016 Jan; 124(1):27-42. PubMed ID: 26230478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential of integrated [18F] fluorodeoxyglucose positron-emission tomography/CT in identifying vulnerable carotid plaques.
    Kwee RM; Truijman MT; Mess WH; Teule GJ; ter Berg JW; Franke CL; Korten AG; Meems BJ; Prins MH; van Engelshoven JM; Wildberger JE; van Oostenbrugge RJ; Kooi ME
    AJNR Am J Neuroradiol; 2011 May; 32(5):950-4. PubMed ID: 21330389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT.
    Hetterich H; Rominger A; Walter L; Habs M; Volpers S; Hacker M; Reiser MF; Bartenstein P; Saam T
    Int J Cardiovasc Imaging; 2016 Jan; 32(1):49-59. PubMed ID: 25898891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of carotid plaque vulnerability in vivo: Correlation between dynamic contrast-enhanced MRI and MRI-modified AHA classification.
    Ge X; Zhou Z; Zhao H; Li X; Sun B; Suo S; Hackett ML; Wan J; Xu J; Liu X
    J Magn Reson Imaging; 2017 Sep; 46(3):870-876. PubMed ID: 28120364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of nonstenosing, complicated atherosclerotic plaques in cryptogenic stroke.
    Freilinger TM; Schindler A; Schmidt C; Grimm J; Cyran C; Schwarz F; Bamberg F; Linn J; Reiser M; Yuan C; Nikolaou K; Dichgans M; Saam T
    JACC Cardiovasc Imaging; 2012 Apr; 5(4):397-405. PubMed ID: 22498329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inter-reader agreement of
    Johnsrud K; Seierstad T; Russell D; Revheim ME
    JRSM Cardiovasc Dis; 2020; 9():2048004020980941. PubMed ID: 33403110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated EMMPRIN Serum Levels Indicate Plaque Vulnerability in Patients With Asymptomatic High Grade Carotid Stenosis.
    Kampf S; Micko A; Stojkovic S; Nackenhorst M; Demyanets S; Eilenberg WH; Krenn C; Wojta J; Neumayer C
    Eur J Vasc Endovasc Surg; 2023 Apr; 65(4):474-483. PubMed ID: 36529365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 18FDG PET and ultrasound echolucency in carotid artery plaques.
    Graebe M; Pedersen SF; Højgaard L; Kjaer A; Sillesen H
    JACC Cardiovasc Imaging; 2010 Mar; 3(3):289-95. PubMed ID: 20223427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The complementary roles of dynamic contrast-enhanced MRI and 18F-fluorodeoxyglucose PET/CT for imaging of carotid atherosclerosis.
    Calcagno C; Ramachandran S; Izquierdo-Garcia D; Mani V; Millon A; Rosenbaum D; Tawakol A; Woodward M; Bucerius J; Moshier E; Godbold J; Kallend D; Farkouh ME; Fuster V; Rudd JH; Fayad ZA
    Eur J Nucl Med Mol Imaging; 2013 Dec; 40(12):1884-93. PubMed ID: 23942908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging Atherosclerosis in the Carotid Arteries with F-18-Fluoro-2-deoxy-D-glucose Positron Emission Tomography: Effect of Imaging Time after Injection on Quantitative Measurement.
    Oh M; Kim JY; Shin KH; Park SH; Ryu JS; Kim JS; Kim HJ; Kang DW; Moon DH
    Nucl Med Mol Imaging; 2010 Dec; 44(4):261-6. PubMed ID: 24899962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advanced ultrasound methods in assessment of carotid plaque instability: a prospective multimodal study.
    Zamani M; Skagen K; Scott H; Russell D; Skjelland M
    BMC Neurol; 2020 Jan; 20(1):39. PubMed ID: 31996153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uptake of F-18 FDG and ultrasound analysis of carotid plaque.
    Choi YS; Youn HJ; Chung WB; Hwang HJ; Lee DH; Park CS; Lee JB; Kim PJ; Chung WS; Lee MY; Seung KB; Chung YA
    J Nucl Cardiol; 2011 Apr; 18(2):267-72. PubMed ID: 21279492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-inflammatory and morphologic effects of pitavastatin on carotid arteries and thoracic aorta evaluated by integrated backscatter trans-esophageal ultrasound and PET/CT: a prospective randomized comparative study with pravastatin (EPICENTRE study).
    Watanabe T; Kawasaki M; Tanaka R; Ono K; Kako N; Saeki M; Onishi N; Nagaya M; Sato N; Miwa H; Arai M; Noda T; Watanabe S; Minatoguchi S
    Cardiovasc Ultrasound; 2015 Apr; 13():17. PubMed ID: 25889304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous assessment of microcalcifications and morphological criteria of vulnerability in carotid artery plaque using hybrid
    Mechtouff L; Sigovan M; Douek P; Costes N; Le Bars D; Mansuy A; Haesebaert J; Bani-Sadr A; Tordo J; Feugier P; Millon A; Luong S; Si-Mohamed S; Collet-Benzaquen D; Canet-Soulas E; Bochaton T; Crola Da Silva C; Paccalet A; Magne D; Berthezene Y; Nighoghossian N
    J Nucl Cardiol; 2022 Jun; 29(3):1064-1074. PubMed ID: 33145738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plaque features associated with increased cerebral infarction after minor stroke and TIA: a prospective, case-control, 3-T carotid artery MR imaging study.
    Lindsay AC; Biasiolli L; Lee JM; Kylintireas I; MacIntosh BJ; Watt H; Jezzard P; Robson MD; Neubauer S; Handa A; Kennedy J; Choudhury RP
    JACC Cardiovasc Imaging; 2012 Apr; 5(4):388-96. PubMed ID: 22498328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of Atherosclerotic Inflammation by
    Tarkin JM; Joshi FR; Evans NR; Chowdhury MM; Figg NL; Shah AV; Starks LT; Martin-Garrido A; Manavaki R; Yu E; Kuc RE; Grassi L; Kreuzhuber R; Kostadima MA; Frontini M; Kirkpatrick PJ; Coughlin PA; Gopalan D; Fryer TD; Buscombe JR; Groves AM; Ouwehand WH; Bennett MR; Warburton EA; Davenport AP; Rudd JH
    J Am Coll Cardiol; 2017 Apr; 69(14):1774-1791. PubMed ID: 28385306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of symptomatic and asymptomatic atherosclerotic carotid plaques using parallel imaging and 3 T black-blood in vivo CMR.
    Grimm JM; Schindler A; Freilinger T; Cyran CC; Bamberg F; Yuan C; Reiser MF; Dichgans M; Freilinger C; Nikolaou K; Saam T
    J Cardiovasc Magn Reson; 2013 May; 15(1):44. PubMed ID: 23705576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.